Navigation Links
J. Craig Venter, Human Genome Pioneer, to Receive Award at Vietnam Veterans of America's National Leadership Conference
Date:4/24/2008

WASHINGTON, April 24 /PRNewswire-USNewswire/ -- The visionary biologist and intellectual entrepreneur J. Craig Venter will receive the Vietnam Veterans of America Excellence in the Sciences Award at VVA's biennial National Leadership Conference on Saturday, July 19, in Greenville, South Carolina. The honor will be presented at the conference's final event, the Awards Banquet, at the Hyatt Regency Greenville, the site of the Leadership Conference.

"Craig Venter has been one of the world's most accomplished -- and famous -- scientists since he pioneered the mapping of the human genome in 2000," said VVA President John Rowan. "What many people don't know is that Dr. Venter served as a Navy corpsman -- a medic -- in the Vietnam War, an experience that he says has shaped much of his adult life. We are extremely proud to honor a fellow Vietnam veteran for his unmatched contributions to science in decoding the human genome, and for the forming of the J. Craig Venter Institute, a world leader in genomic research."

Chris Noel, who as a young actress put her career on hold to host a popular radio show in Vietnam on the Armed Forces Network, will receive the President's Award for Excellence in the Arts at the Awards Banquet. W.D. Ehrhart, the celebrated poet, writer, scholar and teacher who served as a U.S. Marine in the Vietnam War, will receive the VVA Excellence in the Arts Award.

The Leadership Conference brings together hundreds of Vietnam veteran advocates from around the nation. They will take part in four days of seminars, meetings, and other activities. Opening Ceremonies will be held Wednesday, July 16. VVA's supporting organization, the Associates of Vietnam Veterans of America, will hold its biennial convention and national elections, and the Veterans of Modern Warfare (VMW) will have its founding National Convention concurrently with the Leadership Conference.


'/>"/>
SOURCE Vietnam Veterans of America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Queen Latifahs Travlin Light Tour to Be Sponsored by Jenny Craig
2. Cooper Clinic at Craig Ranch Opens Signaling the Next Phase of CooperLife Health-Focused Residential Community in McKinney
3. Jenny Craig Offers Help to Stranded Clients
4. Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
5. Cardinal Health Names Former Acting Deputy U.S. Attorney General Craig S. Morford to Chief Compliance Officer Post
6. Embryonic Stem Cells Repair Human Heart
7. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
8. Human Papilloma Virus vaccines may decrease chances of oral cancer
9. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
10. MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources
11. Toddler Study Proves Humans Outsmart Apes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...firm Replikins Ltd. today issued its latest bioche... shows that the lethality of the virus has dropped...s current outbreak in the spring of 2009 to restin... The H1N1 infectivity count, however, remains incr...ovember 27, 2009 -- Biotech firm Replikins Ltd., w...
(Date:11/27/2009)...7/PRNewswire-FirstCall/--ShamirOpticalIndustryLtd....vativeproductsandtechnologytotheophthalmiclensmark...dadividenddistributioninanaggregateamountofUS$10mi...er25,2009representativerateofexchange),orapproxima...25,2009representativerateofexchange)perordinarysha...
(Date:11/27/2009)...ealth™ announced today that Spectrum Health ...d Enterprise orthopedic templating solution and it... (PRWEB) November 27, 2009 -- Voyant...h (Grand Rapids, Michigan) has licensed its Trauma...its TraumaCad Extend workflow solution, to allow i...
(Date:11/26/2009)...wswire/--ThediabetespopulationintheUnitedStateswil...ndingonthediseaseisprojectedtohit$336billion,upfro...ecemberissueof DiabetesCare .TheNational ChangingD...commissionedtheanalysisbyateamfromtheUniversityofC...ericanslivingwithdiabeteswillrisefrom23.7millionin...
(Date:11/26/2009)...letters from the North Pole, Textsanta.net lets pa...Santa , North Pole, AK (P...ciencies at the North Pole Santa Claus has added S...he globe informed of his Christmas progress at the...epartment have identified a large and growing perc...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...ormone replacement therapy (HRT) should not be pre...opause to help prevent chronic conditions such as ... view that HRT is a safe short term treatment for ... postmenopausal women taking HRT had more heart at...
... the UK could prevent up to 3200 deaths from heart...n the Journal of Epidemiology and Community Health... is already applied to confectionery, ice cream, s...te the likely impact of price rises on demand of a...
...University study published in the July issue of th...s seldom require screening for substance abuse an... improve detection. This may be a missed ...nstance Horgan, director of the Institute for Beha...
...lobin levels to help dialysis patients One... anemia. In order to live a better quality life, d...ate hemoglobin level. Thus anemia correction is a ...ow is the drug called erythropoiesis-stimulating a...
...ow and middle-income countries can turn out econom...clusion was reached by A UCSF-led team of researc...underway in countries like India, South Africa, Ug...th the recent report from the Global HIV Preventio...
...ts reaction to a particular variety of sugar prese...ording to Biology textbooks neutrophils are regard...rm an integral part of blood. They are the policem...uder that invades the body. A new study shows that...
Other Medicine News:Health News:Study Confirms No HRT Benefit for Older Women 2Health News:Study Confirms No HRT Benefit for Older Women 3Health News:Fat Tax Could Avoid Considerable Amount of Heart Attack and Stroke Deaths Annually 2Health News:Screening for Behavioral Health 2Health News:Analysis of Hemoglobin Level Control in Dialysis Patients 2Health News:Analysis of Hemoglobin Level Control in Dialysis Patients 3Health News:HIV Prevention Programs on a Massive Scale Turn Out Economical 2Health News:WBC Selective About Sugar 2
(Date:11/25/2009)...25/PRNewswire/--RegadoBiosciences,aprivatelyheldco...withactivecontrolagents,announcedthatDavidMazzo,Ph...y21stAnnualHealthCareConferenceattheNewYorkPalaceH...nat1:10pm(EST)onTuesday,December1andwillincludeano...developmentprogram,theanticoagulantsystem,REG1.The...
(Date:11/25/2009)...5/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ...ebloodanalysissystems,announcedtodaythatClintSever...the21stAnnualPiperJaffrayHealthCareConferenceonWed...lbeheldattheNewYorkPalaceHotelinNewYorkCity. ,,...dmarketsportablebloodanalysissystemsforuseinanyvet...
(Date:11/25/2009).../PRNewswire/--CempraPharmaceuticalsInc.todayannoun...tiveofficer,willpresentatthePiperJaffray21stAnnual...tTheNewYorkPalaceHotelinNewYorkCity.Dr.Fernandeswi...ticclinicalprogramsforthetreatmentofdrug-resistant...uticals ,, Foundedin2006,CempraPharmaceuticals...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 1AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 2AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 3AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 4Women 26apos 3Bs Health Expert Dr Susan Lark Featured on Searchbloodsugar com 50863 1Women 26apos 3Bs Health Expert Dr Susan Lark Featured on Searchbloodsugar com 50863 2Women 26apos 3Bs Health Expert Dr Susan Lark Featured on Searchbloodsugar com 50863 3Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 1Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 2Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 3Urgent 28R 29 PC and Macroplastique 28R 29 Featured in Numerous IUGA 2009 Sessions 50859 4
... Dec. 9 Portola,Pharmaceuticals, a biopharmaceuti...de significant advances in cardiovascular disease,...that it has initiated patient enrollment in,INNOVA...28, the Company,s,novel P2Y12 ADP receptor antagon...s coronary intervention (PCI). , "With the i...
...nnium: The Takeda Oncology Company today reported ...ients from the large, international Phase III VIST...for patients with previously untreated multiple my...P). The VELCADE combination demonstrated consisten...ose with poor prognostic characteristics, such as ...
Other Medicine Technology:Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention 2Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6
Anorectal Water Perfused Catheters
AnorectalSolid State Manometry Catheters
Multi-Use Adult Anorectal Water Perfused Catheters
Multi-Use Adult Esophageal Water Perfused Catheters
Medicine Products: